473 related articles for article (PubMed ID: 16020950)
1. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting.
Rubboli A; Milandri M; Castelvetri C; Cosmi B
Cardiology; 2005; 104(2):101-6. PubMed ID: 16020950
[TBL] [Abstract][Full Text] [Related]
2. Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).
Dewilde W; Berg JT
Am Heart J; 2009 Nov; 158(5):713-8. PubMed ID: 19853687
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.
Gao F; Zhou YJ; Wang ZJ; Yang SW; Nie B; Liu XL; Jia de A; Yan ZX
Int J Cardiol; 2011 Apr; 148(1):96-101. PubMed ID: 21185095
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.
Sarafoff N; Ndrepepa G; Mehilli J; Dörrler K; Schulz S; Iijima R; Byrne R; Schömig A; Kastrati A
J Intern Med; 2008 Nov; 264(5):472-80. PubMed ID: 18624903
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
Baber U; Akhter M; Kothari S; Sharma SK; Kini A
J Invasive Cardiol; 2010 Feb; 22(2):80-3. PubMed ID: 20124594
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: a review of the available evidence and practical suggestions for the clinician.
Rubboli A; Verheugt FW
Int J Cardiol; 2008 Jan; 123(3):234-9. PubMed ID: 17434621
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
L'Allier PL; Aronow HD; Cura FA; Bhatt DL; Albirini A; Schneider JP; Topol EJ; Ellis SG
Can J Cardiol; 2003 Aug; 19(9):1041-6. PubMed ID: 12915931
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome.
Persson J; Lindbäck J; Hofman-Bang C; Lagerqvist B; Stenestrand U; Samnegard A
EuroIntervention; 2011 Apr; 6(9):1046-52, 8-9. PubMed ID: 21518675
[TBL] [Abstract][Full Text] [Related]
10. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2.
Tada T; Natsuaki M; Morimoto T; Furukawa Y; Nakagawa Y; Byrne RA; Kastrati A; Kadota K; Iwabuchi M; Shizuta S; Tazaki J; Shiomi H; Abe M; Ehara N; Mizoguchi T; Mitsuoka H; Inada T; Araki M; Kaburagi S; Taniguchi R; Eizawa H; Nakano A; Suwa S; Takizawa A; Nohara R; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
Circ Cardiovasc Interv; 2012 Jun; 5(3):381-91. PubMed ID: 22619260
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention.
D'Ascenzo F; Taha S; Moretti C; Omedè P; Grossomarra W; Persson J; Lamberts M; Dewilde W; Rubboli A; Fernández S; Cerrato E; Meynet I; Ballocca F; Barbero U; Quadri G; Giordana F; Conrotto F; Capodanno D; DiNicolantonio J; Bangalore S; Reed M; Meier P; Zoccai G; Gaita F
Am J Cardiol; 2015 May; 115(9):1185-93. PubMed ID: 25799015
[TBL] [Abstract][Full Text] [Related]
13. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis.
Lee SW; Park SW; Hong MK; Kim YH; Lee BK; Song JM; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SJ
J Am Coll Cardiol; 2005 Nov; 46(10):1833-7. PubMed ID: 16286167
[TBL] [Abstract][Full Text] [Related]
14. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
15. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
16. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D
Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846
[TBL] [Abstract][Full Text] [Related]
17. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.
Rubboli A; Bolognese L; Di Pasquale G; Galvani M; La Vecchia L; Maggioni AP
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):200-3. PubMed ID: 19377385
[TBL] [Abstract][Full Text] [Related]
18. Tirofiban use with clopidogrel and aspirin decreases adverse cardiovascular events after percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.
Sethi A; Bahekar A; Doshi H; Bhuriya R; Bedi U; Singh S; Khosla S
Can J Cardiol; 2011; 27(5):548-54. PubMed ID: 21871775
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
[TBL] [Abstract][Full Text] [Related]
20. Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel.
Pasceri V; Patti G; Pristipino C; Pelliccia F; Irini D; Varveri A; Roncella A; Di Sciascio G; Speciale G
Catheter Cardiovasc Interv; 2010 May; 75(6):936-42. PubMed ID: 20146326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
